News
HER2+ breast cancer usually undergo preoperative therapy with multi-agent chemotherapy in combination with anti-HER2 ...
Personalis, Inc. , a leader in advanced genomics for precision oncology, announced the presentation of new clinical results from the PREDICT DNA and SCANDARE studies highlighting the capabilities of ...
6h
Bravo TV on MSNMonyetta Shaw-Carter Reveals Her Breast Cancer Diagnosis: "I Was Afraid. I Was Angry"Monyetta Shaw-Carter privately faced “one of the biggest battles of [her] life”… and came out victorious. The Real Housewives ...
A cancer and exercise researcher at the University of Leeds has completed the world’s highest marathon and a 6000m mountain ...
THP combines one chemotherapy drug (a taxane) with the HER2-targeting drugs trastuzumab and pertuzumab. THP is a standard treatment for patients with metastatic HER2+ breast cancer. Previous small ...
Treating breast cancer patients with AstraZeneca’s experimental pill camizestrant at the first sign of resistance to standard treatments cut the risk of disease progression or death by half, a finding ...
When you’re newly diagnosed, emotional distress, depression, and anxiety, absolutely play into your overall success as a patient,” said Alicia Arnold, DO, an associate professor of ...
After breastfeeding triplets, Lisa Medlen wanted her body to look the way it did before pregnancy. She saw a cosmetic surgeon about getting a breast lift but he recommended implants. He never ...
Lobular breast cancer is more common than ovarian or skin cancer but there is little awareness around it, despite it being ...
21h
Inquirer Technology on MSNUP study finds method that can detect breast cancer earlyDiliman have developed an analytical model that could detect early signs of metastasis, or spread of tumor, in breast cancer ...
Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...
Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds
Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results